Literature DB >> 15039383

Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).

Satoko Tahara-Hanaoka1, Kazuko Shibuya, Yuko Onoda, Hua Zhang, Satoshi Yamazaki, Akitomo Miyamoto, Shin-Ichiro Honda, Lewis L Lanier, Akira Shibuya.   

Abstract

CD226 (DNAM-1) is an adhesion molecule involved in NK and T cell-mediated cytotoxicity against certain tumors. Here, we have identified the human poliovirus receptor-related (PRR) family members CD155 [poliovirus receptor (PVR)] and CD112 (nectin-2/PRR-2) as the ligands for human CD226. Ectopic expression of human CD155 and/or CD112 rendered mouse BW5147 T cells more susceptible to IL-2-activated T and NK cell-mediated cytotoxicity, and killing was specifically inhibited by anti-CD226 mAb, demonstrating functional interactions of CD226 with CD155 and CD112. Although the binding affinities between soluble CD226 and CD155 or CD112 were comparable, the homophilic interaction of cell-surface CD112 may adversely affect CD226 binding to CD112. We also demonstrate that ligation of CD226 and LFA-1 with their respective ligands cooperates in triggering cytotoxicity and cytokine secretion by T and NK cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039383     DOI: 10.1093/intimm/dxh059

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  113 in total

Review 1.  Cell surface signaling molecules in the control of immune responses: a tide model.

Authors:  Yuwen Zhu; Sheng Yao; Lieping Chen
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

2.  miR-30c-1* promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1.

Authors:  Jiuyu Gong; Rongrong Liu; Ran Zhuang; Yun Zhang; Liang Fang; Zhuwei Xu; Liang Jin; Tao Wang; Chaojun Song; Kun Yang; Yuying Wei; Angang Yang; Boquan Jin; Lihua Chen
Journal:  Cancer Sci       Date:  2012-02-13       Impact factor: 6.716

3.  The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.

Authors:  Giulia Matusali; Marina Potestà; Angela Santoni; Cristina Cerboni; Margherita Doria
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

4.  Gene expression analyses of mouse aortic endothelium in response to atherogenic stimuli.

Authors:  Ayca Erbilgin; Nathan Siemers; Paul Kayne; Wen-pin Yang; Judith Berliner; Aldons J Lusis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-29       Impact factor: 8.311

5.  Co-inhibition of TIGIT, PD1, and Tim3 reverses dysfunction of Wilms tumor protein-1 (WT1)-specific CD8+ T lymphocytes after dendritic cell vaccination in gastric cancer.

Authors:  Xu Lu; Jingwei Liu; Peilin Cui; Tao Liu; Chunmei Piao; Xianghong Xu; Qike Zhang; Man Xiao; Xuesong Liu; Yue Wang; Lin Yang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

6.  Vstm3 is a member of the CD28 family and an important modulator of T-cell function.

Authors:  Steven D Levin; David W Taft; Cameron S Brandt; Christoph Bucher; Edward D Howard; Eric M Chadwick; Janet Johnston; Angela Hammond; Kristen Bontadelli; Daniel Ardourel; LuAnn Hebb; Anitra Wolf; Thomas R Bukowski; Mark W Rixon; Joseph L Kuijper; Craig D Ostrander; James W West; Janine Bilsborough; Brian Fox; Zeren Gao; Wenfeng Xu; Fred Ramsdell; Bruce R Blazar; Katherine E Lewis
Journal:  Eur J Immunol       Date:  2011-03-18       Impact factor: 5.532

Review 7.  Mechanisms of NK cell activation: CD4(+) T cells enter the scene.

Authors:  Franck Bihl; Claire Germain; Carmelo Luci; Veronique M Braud
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

Review 8.  Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Authors:  Paola Kučan Brlić; Tihana Lenac Roviš; Guy Cinamon; Pini Tsukerman; Ofer Mandelboim; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

9.  IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killing.

Authors:  Matthias Braun; Marie L Ress; Young-Eun Yoo; Claus J Scholz; Matthias Eyrich; Paul G Schlegel; Matthias Wölfl
Journal:  Oncoimmunology       Date:  2016-05-19       Impact factor: 8.110

10.  Increased levels of soluble CD226 in sera accompanied by decreased membrane CD226 expression on peripheral blood mononuclear cells from cancer patients.

Authors:  Zhuwei Xu; Tao Zhang; Ran Zhuang; Yun Zhang; Wei Jia; Chaojun Song; Kun Yang; Angang Yang; Boquan Jin
Journal:  BMC Immunol       Date:  2009-06-02       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.